Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 266 | 3 | NUCL MED//RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING//JOURNAL OF NUCLEAR MEDICINE | 45145 |
| 2612 | 2 | BONE SCINTIGRAPHY//BONE SCAN//BONE MARROW SCINTIGRAPHY | 3824 |
| 28315 | 1 | BONE TO SOFT TISSUE RATIO//TC 99M METHYLENE DIPHOSPHONATE//BONE PLASMA CLEARANCE | 228 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | BONE TO SOFT TISSUE RATIO | authKW | 311020 | 1% | 75% | 3 |
| 2 | TC 99M METHYLENE DIPHOSPHONATE | authKW | 276455 | 3% | 33% | 6 |
| 3 | BONE PLASMA CLEARANCE | authKW | 177723 | 1% | 43% | 3 |
| 4 | ADRENERGIC BETA RECEPTOR AGONISTS ADVERSE EFFECTS | authKW | 138232 | 0% | 100% | 1 |
| 5 | AGE RELATED BONE UPTAKE | authKW | 138232 | 0% | 100% | 1 |
| 6 | BONE AND BONES DIAGNOSIS | authKW | 138232 | 0% | 100% | 1 |
| 7 | BONE METABOLISM INDICATOR IBM | authKW | 138232 | 0% | 100% | 1 |
| 8 | BONE SOFT TISSUE RATIO B ST RATIO | authKW | 138232 | 0% | 100% | 1 |
| 9 | BONE UPTAKE MEASUREMENT | authKW | 138232 | 0% | 100% | 1 |
| 10 | CENT XRAY | address | 138232 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Radiology, Nuclear Medicine & Medical Imaging | 3984 | 51% | 0% | 116 |
| 2 | MEDICINE, MISCELLANEOUS | 346 | 1% | 0% | 2 |
| 3 | Orthopedics | 213 | 9% | 0% | 20 |
| 4 | Medicine, General & Internal | 79 | 10% | 0% | 23 |
| 5 | Endocrinology & Metabolism | 61 | 7% | 0% | 17 |
| 6 | Emergency Medicine | 51 | 2% | 0% | 5 |
| 7 | Anthropology | 38 | 2% | 0% | 5 |
| 8 | Engineering, Biomedical | 31 | 4% | 0% | 8 |
| 9 | Surgery | 25 | 8% | 0% | 18 |
| 10 | Medicine, Research & Experimental | 21 | 5% | 0% | 11 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CENT XRAY | 138232 | 0% | 100% | 1 |
| 2 | CLIN NEPHROL HYPERTENS FAMILIAR MED | 138232 | 0% | 100% | 1 |
| 3 | MED BIOL MED SCI | 138232 | 0% | 100% | 1 |
| 4 | MED DIAGNOST RADIOLNUCL MED SECT | 138232 | 0% | 100% | 1 |
| 5 | MED NUCL EXPT | 138232 | 0% | 100% | 1 |
| 6 | UNIV NUCL MED RADIAT PROTECT | 138232 | 0% | 100% | 1 |
| 7 | ZAKLAD DIAGNOSTYKI TER II RADIOLOGICZNEJ IZO | 138232 | 0% | 100% | 1 |
| 8 | CLIN NUCL MED SECT | 69115 | 0% | 50% | 1 |
| 9 | DIALYSIS UNIV | 69115 | 0% | 50% | 1 |
| 10 | SAN GIUSEPPE FATEBENEFRATELLI | 69115 | 0% | 50% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 20689 | 10% | 1% | 22 |
| 2 | JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES | 14668 | 3% | 2% | 6 |
| 3 | NUKLEARMEDIZIN | 13850 | 3% | 2% | 6 |
| 4 | JOURNAL OF NUCLEAR MEDICINE | 7089 | 10% | 0% | 23 |
| 5 | METABOLIC BONE DISEASE & RELATED RESEARCH | 6719 | 1% | 2% | 3 |
| 6 | NUCLEAR MEDICINE COMMUNICATIONS | 4687 | 5% | 0% | 12 |
| 7 | NUKLEARMEDIZIN-NUCLEAR MEDICINE | 4191 | 3% | 1% | 6 |
| 8 | ANNALS OF NUCLEAR MEDICINE | 3469 | 3% | 0% | 7 |
| 9 | JOURNAL DE BIOPHYSIQUE & MEDECINE NUCLEAIRE | 3174 | 1% | 1% | 2 |
| 10 | PROCEEDINGS OF THE EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION | 2854 | 1% | 1% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |